Zymeworks ZYME
NASDAQ ZYME
$29.43 -2.03 (-6.45%)
As of: Nov 11, 2026 · 2:51 PM EST

Zymeworks (ZYME) Other Accumulated Expenses (2021)

Updated

Zymeworks' Other Accumulated Expenses was $22,000 in Q4 2021.

Analysis

Zymeworks (ZYME) Other Accumulated Expenses (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Zymeworks 2.24 Bn 1.27 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 22,000.00
API Access

Zymeworks Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ZYME&period=max&api_key=YOUR_API_KEY